Cargando…
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota tr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439665/ https://www.ncbi.nlm.nih.gov/pubmed/37602044 http://dx.doi.org/10.7759/cureus.42120 |
_version_ | 1785093000693547008 |
---|---|
author | Jaramillo, Arturo P Awosusi, Babatope L Ayyub, Javaria Dabhi, Karan Nareshbhai Gohil, Namra V Tanveer, Nida Hussein, Sally Pingili, Shravya Makkena, Vijaya Krishna |
author_facet | Jaramillo, Arturo P Awosusi, Babatope L Ayyub, Javaria Dabhi, Karan Nareshbhai Gohil, Namra V Tanveer, Nida Hussein, Sally Pingili, Shravya Makkena, Vijaya Krishna |
author_sort | Jaramillo, Arturo P |
collection | PubMed |
description | Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota transplantation (FMT) has many benefits in the treatment of inflammatory bowel disease (IBD) by restoring intestinal homeostasis and reducing clinical symptoms. In mildly symptomatic patients with UC, an FMT treatment combined with an anti-inflammatory diet can produce remission, which would then be followed by a diet that maintained the anti-inflammatory effects. The efficacy of FMT consists of preventing flares or the consequences of IBD. As a result, we must emphasize that more investigation should be done before developing a therapeutic procedure for FMT in IBD and its associated consequences. |
format | Online Article Text |
id | pubmed-10439665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104396652023-08-20 Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review Jaramillo, Arturo P Awosusi, Babatope L Ayyub, Javaria Dabhi, Karan Nareshbhai Gohil, Namra V Tanveer, Nida Hussein, Sally Pingili, Shravya Makkena, Vijaya Krishna Cureus Internal Medicine Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota transplantation (FMT) has many benefits in the treatment of inflammatory bowel disease (IBD) by restoring intestinal homeostasis and reducing clinical symptoms. In mildly symptomatic patients with UC, an FMT treatment combined with an anti-inflammatory diet can produce remission, which would then be followed by a diet that maintained the anti-inflammatory effects. The efficacy of FMT consists of preventing flares or the consequences of IBD. As a result, we must emphasize that more investigation should be done before developing a therapeutic procedure for FMT in IBD and its associated consequences. Cureus 2023-07-19 /pmc/articles/PMC10439665/ /pubmed/37602044 http://dx.doi.org/10.7759/cureus.42120 Text en Copyright © 2023, Jaramillo et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Jaramillo, Arturo P Awosusi, Babatope L Ayyub, Javaria Dabhi, Karan Nareshbhai Gohil, Namra V Tanveer, Nida Hussein, Sally Pingili, Shravya Makkena, Vijaya Krishna Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title | Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title_full | Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title_fullStr | Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title_full_unstemmed | Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title_short | Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review |
title_sort | effectiveness of fecal microbiota transplantation treatment in patients with recurrent clostridium difficile infection, ulcerative colitis, and crohn’s disease: a systematic review |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439665/ https://www.ncbi.nlm.nih.gov/pubmed/37602044 http://dx.doi.org/10.7759/cureus.42120 |
work_keys_str_mv | AT jaramilloarturop effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT awosusibabatopel effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT ayyubjavaria effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT dabhikarannareshbhai effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT gohilnamrav effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT tanveernida effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT husseinsally effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT pingilishravya effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview AT makkenavijayakrishna effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview |